Titan Biotech Ltd — Insider Trading, 22-12-2025: Insider Trading / SAST

The company has initiated the closure of its trading window for designated persons and their immediate relatives. This action is taken in anticipation of the upcoming announcement of the financial results for the quarter and half-year. The trading window will remain closed until after these financial results are publicly disclosed. This is a common practice to uphold market integrity and prevent insider trading during periods of sensitive financial information, impacting only company insiders and ensuring a fair market for all investors.